Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MRNA-1083 by Moderna for Influenzavirus B Infections: Likelihood of Approval
MRNA-1083 is under clinical development by Moderna and currently in Phase II for Influenzavirus B Infections. According to GlobalData, Phase...